Skip to content Skip to footer

EVENTS

Drug Discovery and Innovation Programme 2025
Drug Discovery and Innovation Programme 2025 | Sep 25-26 |Barcelona, Spain
A B2B event designed to connect Drug Discovery Experts, Biotech Innovation, and emerging technologies. This expert-led, two-day event blends keynotes, case studies, panel discussions, and 1:1 meetings to turn research into real-world impact. For any queries, reach out to Tina Aston at ta@worldbigroup.com Related Post: Clinical Trials Operations DACH 2025 | Sep 18 | Basel,…
Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025
Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 takes place in Vösendorf, Austria on 24-25 November. The 5th anniversary edition of AUTOMA+ gathers leading innovators and IT professionals to discuss the directions of the advanced industry shift and celebrate this milestone together.   The 2-day agenda includes topics:  Ethical and human-centric AI;  Smart manufacturing techniques (digital…
2025 BioPharma Deals: The Survival Series | Nov 24-25 | Munich, Germany
2025 BioPharma Deals: The Survival Series | Nov 24-25 | Munich, Germany
BioPharma Deals: The Survival Series brings together leaders from biotech, pharma, investment, CRO/CDMO, legal, and advisory sectors for a high-impact event focused on pragmatic deal-making, new financing models, early IPOs, and unconventional partnerships. This is not a conference about the distant future. It's a working summit for what can be done now. It's about survival,…
HLTH USA 2025 | Oct 19-22 | Las Vegas, NV 
EVERYONE has a heroic story to tell, their own legend to fulfill and HLTH is forging ahead into new realms of possibilities, gathering 12,000+ influential leaders, executives and visionaries who are passionately creating the next generation of healthcare. At HLTH you can foster meaningful connections, gain insights on cutting-edge trends, enhance your professional journey, or…
Discovery & Development Summit Asia 2025
Discovery & Development Summit Asia 2025 is Global Engage’s inaugural platform that brings together the Drug Discovery & Development, Nucleic Acid Therapeutics and Precision Medicine congresses. This summit allows the exploration of the full spectrum of therapeutic innovation, from early-stage discovery to clinical translation and commercialization. Attendees will gain insights into assay development, screening technologies,…
Hlth
2025 | HLTH Europe: 16-19 June | Amsterdam
HLTH Europe is the continent’s #1 healthcare innovation event. Following an enormously successful first event in 2024 and the exponential growth of HLTH in the US, this landmark event is where global expertise meets local insight to address Europe's unique healthcare challenges and opportunities. Don’t miss out on this opportunity to connect with like-minded individuals…
Spotlight_Barbara Albientz
Reuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz
Barbara Albientz, Chief Commercialization Officer, Helvion Pharmaceuticals, joins PharmaShots’ Managing Editor Himanshu Sehgal for a riveting dialogue exchange. Barbara shares her experience from the recently held Reuters Events Pharma 2025, where she joined as an affirmative team member for the debate Reality Check: Is Omnichannel Actually Working? Barbara believes AI will be crucial in segmenting…
Spotlight_Michael Bierl
Reuters Pharma 2025: Post-Conference Talks Featuring Michael Bierl
Michael Bierl, VP, Partnerships and GM at Flatiron Health, joins PharmaShots’ Managing Editor Himanshu Sehgal for an illuminating dialogue exchange. Michael shares his experience from the recently held Reuters Events Pharma 2025, where he joined as a presenter for the case study titled Bridging gaps: Leverage data, tech and RWE for enhanced healthcare access and…
Spotlight_Jayasree Iyer
Reuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer 
Jayasree K. Iyer, CEO of Access to Medicine Foundation, moderated a panel discussion that featured leaders from the 2024 Access to Medicine Index. Jayasree highlighted how biopharma companies foster accessibility to essential medicines in low- and middle-income countries through global partnerships, innovation, and sustainable models. Jayasree talks about the future of Health Equity amidst the…